Access to Medicine Index homepage

Best practice - 20 Nov 2018

DREAMS learns from local young women to reduce HIV

Johnson & Johnson is a partner in DREAMS, a public-private partnership led by PEPFAR, aimed at reducing new HIV infections among young women. The partnership uniquely engages with local young people through workshops to design learning activities.

6th Access to Medicine Index: latest analysis of pharma action.

The Index reports how 20 pharmaceutical companies make medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.

Key finding

Five companies are carrying out 63% of the most urgently needed R&D projects

Pharmaceutical R&D priorities have been identified for people in low- and middle-income countries. Companies are responding: priority R&D accounts for a fifth of all R&D projects analysed.

Key finding

Most key on-patent products have access initiatives, but these are limited in reach

The Index has identified 53 products that are critical candidates for companies’ access initiatives: they are on-patent, first-line therapies seen as essential for all healthcare systems.

View all news

"There have been massive improvements in global health in the past decades, with all major pharmaceutical companies taking action. To close the gaps that remain, a greater diversity of companies must get involved and stay engaged."